Preferred Pharmaceuticals Doxazosin Tablets Recall: Manufacturing Quality Issues
Preferred Pharmaceuticals recalls 4 mg Doxazosin tablets due to manufacturing quality deviations. This affects specific lots produced by Accord Healthcare. Consumers should contact the manufacturer for details.
Recall notice
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Contact the company
What happened, in plain English
Preferred Pharmaceuticals is recalling 4 mg Doxazosin tablets that were manufactured by Accord Healthcare. The recall is due to quality control issues during production that could affect product safety. This is a medication recall for prescription use only. Read more at govinfonow.com/recall/33758-preferred-pharmaceuticals-doxazosin-tablets-recall-manufacturing-quality-issues.
Source Summary by GovInfoNow · govinfonow.com/recall/33758-preferred-pharmaceuticals-doxazosin-tablets-recall-manufacturing-quality-issues · Updated August 17, 2026 · FDA enforcement record: FDA #D-0515-2023
Cite this page
“Preferred Pharmaceuticals Doxazosin Tablets Recall: Manufacturing Quality Issues.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/33758-preferred-pharmaceuticals-doxazosin-tablets-recall-manufacturing-quality-issues. Based on FDA recall #D-0515-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0515-2023%22&limit=1).
Why it’s dangerous
The recall is based on manufacturing quality deviations found during inspections. This means the tablets may not meet the required safety and quality standards. While the exact risk isn't specified, such deviations could potentially affect product safety.
Who’s affected
Prescription drug users who have the specific lot number L1522V of Doxazosin 4 mg tablets from Accord Healthcare in Durham, NC. People with this medication should check their packaging for the lot number and expiration date.
How to tell if you have this one
Check your Doxazosin tablets for the lot number L1522V and expiration date 4/30/2025. The product is a 100-count bottle with NDC 68788-7149-1, manufactured by Accord Healthcare in Durham, NC.
- Brand
Preferred Pharmaceuticals- Category
Drug
All 17 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Ongoing- Distribution
USA Nationwide
| Recall number | Product, codes & lots | Quantity | NDC |
|---|---|---|---|
| D-0511-2023 | Atorvastatin Calcium Tablets, USP, 10 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7630-9; Lot #: A0523D, Exp 5/31/2024, F14220, Exp 7/31/2023, J0622Q; Exp 1/31/2024. | 158 Bottles | — |
| D-0512-2023 | Atorvastatin Calcium Tablets, USP, 20 mg, packaged in: a) 90-count bottle (NDC 68788-7631-9); b) 30-count bottle (NDC 68788-7631-3), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703; a) Lot: B1522B, Exp 4/30/2023; lot:C0222H, C0322B, Exp 5/31/2023; lot: E1022H, F13220, H2222P, Exp 6/30/2023; Lot: I1422V, K01220, Exp 12/31/2023; Lot: L2722H, Exp 3/31/2024; b) Lot:C0322B, Exp 5/31/2023; lot:H1122G, 12322Q, Exp 6/30/2023; lot: J1222U, Exp 12/31/2023. | a) 375 Bottles b) 323 Bottles | — |
| D-0513-2023 | Clopidogrel Tablets USP, 75 mg, 90-count bottles, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-8190-9; Lot: E0922W, G1222E, I0922W and K3022W Exp 10/31/2023. | 72 Bottles | — |
| D-0514-2023 | Doxazosin Tablets, USP, 2 mg, 100-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7328-1; Lot: H3122K, Exp 5/31/2024. | 3 Bottles | — |
| D-0515-2023 | Doxazosin Tablets, USP, 4 mg, 100-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7149-1; Lot: L1522V, Exp 4/30/2025. | 4 Bottles | — |
| D-0516-2023 | Finasteride Tablets, USP, 5 mg, packaged in: a) 30-count bottles (NDC 68788-6976-3); b) 90-count bottles (NDC 68788-6976-9), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703.; a) Lot: A1321V, D0221J, Exp. Date:8/31/2023; Lot: A1322J, Exp. Date: 5/31/2024; Lot: F0221Q, I0121E, I1021R, J1122D, Exp. Date: 10/31/2023; b) Lot: B0422J, Exp. Date: 5/31/2024; Lot: C1721K, Exp. Date: 8/31/2023; Lot: K1022Q, Exp. Date:11/30/2024. | a) 135 Bottles, b) 24 Bottles | — |
| D-0517-2023 | Glimepiride Tablets, USP, 2 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-8095-9; Lot: D0122K, Exp. Date: 6/30/2024; Lot: I1422N, Exp. Date: 9/30/2024; Lot: I2721B, Exp. Date: 1/31/2024. | 17 Bottles | — |
| D-0518-2023 | Montelukast Sodium Tablets, USP, 10 mg, packaged in: a) 30-count bottle (NDC 68788-9438-3); b) 60-count bottle (NDC 68788-9438-6); c) 90-count bottle (NDC 68788-9438-9), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703.; a) Lot: F3021D, Exp 12/31/2023, Lot: L0722T, Exp 5/31/2025; b) Lot: F1021I, Exp 12/31/2023; c) Lot:H1721R, Exp 12/31/2023, Lot: L0722E, Exp 5/31/2025. | a) 266 Bottles, b) not reported, c) 216 Bottles | — |
| D-0519-2023 | Rosuvastatin Tablets, USP, 10 mg, Packaged as: a) 30-count bottle (NDC 68788-7086-3); b) 90-count bottle (NDC 68788-7086-9), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703.; a) Lot: F2022N, Exp. Date: 2/29/2024; b) Lot: F0322I, Exp. Date: 8/31/2023; Lot: J1322H, Exp. Date: 2/29/2024; Lot: K0222N, Exp. Date: 6/30/2024; Lot: L2322D and Lot: L2822J, Exp. Date:7/31/2025. | a) 59 Bottles, b) 77 Bottles | 68788-7086-2, 68788-7086-3, 68788-7086-6, 68788-7086-9 |
| D-0520-2023 | Rosuvastatin Tablets, USP, 5mg, 30-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7971-3; Lot: A1723C, Exp 8/31/2025; Lot: A1922B, Exp 6/30/2024; Lot: D0622M and Lot: F2922I, Exp 7/31/2024; Lot: G3021L, Exp 1/31/2024; Lot:H2622P & Lot: J0722C, Exp 10/31/2024. | 264 Bottles | — |
| D-0521-2023 | Pravastatin Sodium Tablets, USP, 20 mg, 90-count bottle, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-8215-9; Lot: F1021I; H3122J, Exp 4/30/2024 | 24 Bottles | — |
| D-0522-2023 | Simvastatin Tablets, USP, 10 mg, 90-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703, NDC 68788-9747-9; Lot: C2222P, D1522L, E3122D, G2522J, Exp 9/30/2023; Lot: J1222R, Exp 10/31/2023. | 82 Bottles of 90 Tablets | — |
| D-0523-2023 | Simvastatin Tablets, USP, 80 mg, 90-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703, NDC 68788-9429-9; Lot: B0222S, Exp 2/29/2024; Lot: F1121B, G2721L, Exp 11/30/2023. | 57 Bottles | — |
| D-0524-2023 | Simvastatin Tablets, USP, 20 mg, Packaged as: a) 90-count bottle (NDC 68788-9869-9); b) 60-count bottle (NDC 68788-9869-6); c) 30-count bottle (NDC 68788-9869-3), Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703.; a) Lot: A0923R, Exp. Date: 2/28/2025, A1222K, B1822C, Exp. Date: 5/31/2024, C3022D, F2322V, Exp. Date: 6/30/2024, H1522H, Exp. Date: 8/31/2024, I1621O, Exp. Date: 1/31/2024, I2222G, J1822R, Exp. Date: 9/30/2024, L1621N, Exp. Date: 5/31/2024; b) Lot: F0822Q, Exp. Date: 6/30/2024, I0122J, Exp. Date: 8/31/2024, L0821C, Exp. Date: 5/31/2024; c) Lot: I1521P, Exp. Date: 1/31/2024, J1322R, Exp. Date: 9/30/2024, J1821H, Exp. Date: 2/29/2024. | a) 305 Bottles, b) 72 Bottles, c) 617 Bottles | — |
| D-0525-2023 | Simvastatin Tablets, USP, 40 mg, Packaged as: a) 90-count bottle (NDC 68788-9868-9); b) 60-count bottle (NDC 68788-9868-6); c) 30-count bottle (NDC 68788-9868-3), Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703.; a) Lot: B0922G, Exp. Date: 5/31/2023, F0322G, Exp. Date: 7/25/2024, H2622M, Exp. Date: 8/31/2024, J1422B, K0722G, Exp. Date: 10/31/2024, L1922A, Exp. Date: 2/28/2025; b) Lot: F2922S, Exp. Date: 8/31/2023, H0322G Exp. Date: 7/31/2023; c) Lot: A1322I, Exp. Date: 3/31/2023, H1122C, Exp. Date: 8/31/2024. | a) 88 Bottles, b) 3 Bottles, c) 175 Bottles | — |
| D-0526-2023 | Tadalafil Tablets, USP, 20 mg, 7-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703, NDC 68788-8153-7; Lot: C0822E, Exp 1/31/2024, F1121B, Exp 1/31/2024, G2721L, Exp 1/31/2024. | 32 Bottles | 68788-8153-7 |
| D-0527-2023 | Glimepiride Tablets USP, 4 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-8066-9; Lot: H1221Z, I0121J, J0622X, Exp 10/31/2023. | 15 Bottles | — |
What to do — step by step
Check Product Details
Look for the lot number L1522V and expiration date 4/30/2025 on the packaging.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 20 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Preferred Pharmaceuticals recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0515-2023 (March 23, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0515-2023 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.